Biologics and biosimilars Clinical Trials: Active Studies by Market and Country

• 27markets with active trials
• 21,325active studies on Cell Based Immunotherapy
• 31of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Cell Based Immunotherapy21,325Cell Based Immunotherapy: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Immunoglobulin Therapy1,883Immunoglobulin Therapy: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Cord Blood Banking Service1,116Cord Blood Banking Service: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Inflammatory Bowel Disease Treatment925Inflammatory Bowel Disease Treatment: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Microbiome Therapeutics856Microbiome Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Lipid Nanoparticles737Lipid Nanoparticles: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Rheumatoid Arthritis Drugs550Rheumatoid Arthritis Drugs: See them on ClinicalTrials.gov (opens in a new tab)
8. 8Lupus Treatment537Lupus Treatment: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Apheresis Equipments476Apheresis Equipments: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Biosimilar Monoclonal Antibodies456Biosimilar Monoclonal Antibodies: See them on ClinicalTrials.gov (opens in a new tab)
11. 11Biosimilars456Biosimilars: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Psoriasis Treatment412Psoriasis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
13. 13Allogeneic Cell Therapy363Allogeneic Cell Therapy: See them on ClinicalTrials.gov (opens in a new tab)
14. 14Atopic Dermatitis Treatment344Atopic Dermatitis Treatment: See them on ClinicalTrials.gov (opens in a new tab)
15. 15Bispecific Antibodies287Bispecific Antibodies: See them on ClinicalTrials.gov (opens in a new tab)
16. 16Bone Marrow Aspirate Concentrates278Bone Marrow Aspirate Concentrates: See them on ClinicalTrials.gov (opens in a new tab)
17. 17Hemophilia Treatment170Hemophilia Treatment: See them on ClinicalTrials.gov (opens in a new tab)
18. 18mRNA Therapeutics169mRNA Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
19. 19Exosome Therapeutics143Exosome Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
20. 20Severe Asthma Biologics125Severe Asthma Biologics: See them on ClinicalTrials.gov (opens in a new tab)
21. 21Organoids117Organoids: See them on ClinicalTrials.gov (opens in a new tab)
22. 22Hidradenitis Suppurativa Treatment101Hidradenitis Suppurativa Treatment: See them on ClinicalTrials.gov (opens in a new tab)
23. 23Autologous Matrix-induced Chondrogenesis100Autologous Matrix-induced Chondrogenesis: See them on ClinicalTrials.gov (opens in a new tab)
24. 24RNA Interference Therapeutics50RNA Interference Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
25. 25Allergy Immunotherapy27Allergy Immunotherapy: See them on ClinicalTrials.gov (opens in a new tab)
26. 26Senolytics9Senolytics: See them on ClinicalTrials.gov (opens in a new tab)
27. 27Insulin Biosimilars1Insulin Biosimilars: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Detection and Characterization of Host Defense Defects

  NCT00001355Cell Based Immunotherapy

• Retlirafusp Alfa or Adebrelimab Plus SOX as Neoadjuvant Therapy for HER2-Negative Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07924332Cell Based Immunotherapy

• Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  NCT01906385Cell Based Immunotherapy

• Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

  NCT03141684Immunoglobulin Therapy

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  NCT07780656Immunoglobulin Therapy

• Study of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe Eczema

  NCT07932795Immunoglobulin Therapy

• Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

  NCT07619534Cord Blood Banking Service

• 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

  NCT05588141Cord Blood Banking Service

• Natural History Study of Patients With Neurofibromatosis Type I

  NCT00924196Cord Blood Banking Service

• Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative Colitis

  NCT07932691Inflammatory Bowel Disease Treatment

• A Study of SL-325 in Crohn's Disease Patients

  NCT07753850Inflammatory Bowel Disease Treatment

• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  NCT03816345Inflammatory Bowel Disease Treatment

• Molecular and Microbiome Changes During Tirzepatide Treatment and Resistance Training in Obesity

  NCT07931196Microbiome Therapeutics

• Effects of 5-Methyltetrahydrofolic Acid Supplementation on Maternal Health and One-Carbon Metabolism During Lactation

  NCT07508917Microbiome Therapeutics

• Effects of Treatments on Atopic Dermatitis

  NCT01631617Microbiome Therapeutics

• Phase 1/2 Study of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome

  NCT07135050Lipid Nanoparticles

• OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)

  NCT04283227Lipid Nanoparticles

• Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  NCT01306019Lipid Nanoparticles

• An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1

  NCT07932262Rheumatoid Arthritis Drugs

• Pain Phenotyping of Rheumatic Diseases - An Observational Study

  NCT07829497Rheumatoid Arthritis Drugs

• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

  NCT06576271Lupus Treatment

• Deciphering the Genetic Architecture of Autoimmune Diseases

  NCT06948110Lupus Treatment

• Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

  NCT06930352Apheresis Equipments

• Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  NCT03922724Apheresis Equipments

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Oncology
• Autoimmune diseases
• Skin and hair
• Allergies
• Bones and joints
• Genomics
• Neonatal
• Gut health
• Wounds and burns
• Respiratory